Carbamazepine-Induced Sweet Syndrome

Keywords: Carbamazepine/adverse effects, Sweet Syndrome/chemically induced




Download data is not yet available.


- Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30(2): 239-245. PMID: 7249508.

- Villarreal-Villarreal CD, Ocampo-Candiani J, Villarreal-Martínez A. Sweet Syndrome: A Review and Update. Actas Dermosifiliogr 2016; 107(5): 369-78. PMID: 26826881.

- Casarin Costa JR, Virgens AR, de Oliveira Mestre L, Dias NF, Samorano LP, Valente NYS, et al. Sweet Syndrome: Clinical Features, Histopathology, and Associations of 83 Cases. J Cutan Med Surg 2017; 21(3): 211-216. PMID: 28300447.

- Heath MS, Ortega-Loayza AG. Insights Into the Pathogenesis of Sweet's Syndrome. Front Immunol 2019; 12; 10:414. PMID: 30930894.

- Nelson CA, Noe MH, McMahon CM, Gowda A, Wu B, Ashchyan HJ, et al. Sweet syndrome in patients with and without malignancy: A retrospective analysis of 83 patients from a tertiary academic referral center. J Am Acad Dermatol 2018; 78(2): 303-309.e4. PMID: 29107342.

How to Cite
Gomes, N., Cerejeira, A., Martins, D., & Azevedo, F. (2020). Carbamazepine-Induced Sweet Syndrome. Journal of the Portuguese Society of Dermatology and Venereology, 78(4), 395-397.
Dermatoloty Images